Results 91 to 100 of about 274,323 (195)

Prevalencia de síndrome metabólico y relación con eventos cardiovasculares, supervivencia y función del injerto en pacientes con trasplante renal

Revista Colombiana de Cardiología, 2017
Resumen: Introducción: el síndrome metabólico en pacientes trasplantados tiene una prevalencia entre 20 a 65%1. Objetivo: estimar la prevalencia de síndrome metabólico al momento del trasplante renal y su asociación con el desarrollo de eventos ...
Paola K. García, Juan S. Gélvez, Karen Navarro, Kateir Contreras, Martha P. Rodríguez, Camilo González   +5 more
doaj   +1 more source

Cholesterol Goal Attainment in Hypertensive Patients: the Impact of Metabolic Syndrome Components

, 2012
Background: Hypertension and dyslipidemia are potentially modifiable cardiovascular risk factors.Methods: We studied hypertensive outpatients regarding goal attainment in controlling dyslipidemia, according to individual cardiovascular risk profile ...
Batista, Marcelo Costa, Ribeiro, Hercules Ferreira, Oliveira Rodrigues, Cassio Jose de [UNIFESP], Zanella, Maria Teresa, Ribeiro, Artur Beltrame   +4 more
core   +1 more source

Effects of maternal high fat diet and pharmacological intervention on the developmental origins of metabolic & cardiovascular disease

, 2011
A high fat (HF) diet leads to hypercholesterolemia and predisposes the individual to developing cardiovascular disease (CVD). We hypothesised that mother‘s HF diet before and during pregnancy and lactation can also influence predisposition to CVD in ...
Elahi, Maqsood M.
core  

Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome

Future Cardiology
Recent trials underscore the cardiovascular (CV), renal, and metabolic benefits of semaglutide in individuals with and without type 2 diabetes (T2D). In T2D, semaglutide enhances glycemic control, reduces major adverse CV events (MACE), and slows chronic kidney disease (CKD) progression.
openaire   +2 more sources

Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome

Lipids in Health and Disease
Background Cardiovascular-kidney-metabolic (CKM) syndrome is characterized as a systemic disease resulting from the pathophysiological interplay among metabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease (CVD).
Jiao Tang, Zhehao Xu, Li Ren, Jiahua Xu, Xin Chen, Yian Jin, Ruiyun Liang, Huanji Zhang   +7 more
doaj   +1 more source

Epicardial Fat Tissue Thickness Correlates with Endothelial Dysfunction and Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome

, 2010
Background: Epicardial adipose tissue has shown to be related to cardiovascular risk. The aim of this study is to investigate the relationship between epicardial adiposity and endothelial function in metabolic syndrome.
YAVUZ, DİLEK, ÜSTAY, ÖZLEM
core   +1 more source

Estimated glucose disposal rate and mortality risk in cardiovascular–kidney–metabolic syndrome: a population-based study

BMC Endocrine Disorders
Background Cardiovascular–kidney–metabolic (CKM) syndrome is a systemic disorder characterized by the interrelated dysfunction of metabolic abnormalities, chronic kidney disease, and cardiovascular injury, significantly increasing the risk of ...
Zheng Zhang, Chao Fu, Yiyi Chai, Yanrong Gu, Xiaomin Wu, Dou Zhu, Ping Lin, Bo Yu, Ling Li   +8 more
doaj   +1 more source

Nutrients and pharmacological management of Metabolic syndrome

, 2021
Metabolic syndrome is a public health problem defined by a cluster of interconnected components that increase the risk of cardiovascular atherosclerotic diseases and T2DM.
Ghim, Nayoung
core  

Laser therapy in metabolic syndrome-related kidney injury

, 2013
Metabolic syndrome is characterized by hyperglycemia, hypertension, dyslipidemia and obesity. Diabetes and hypertension are the main causes of chronic end-stage kidney disease in humans.
Joeken, Stephan, Ucero Herrería, Álvaro Conrado, Sabban, Bettina, Carrasco, Susana, Ortiz, Alberto, Benito Martín, Alberto   +5 more
core   +1 more source

Exercise in CKM syndrome progression: a stage-specific approach to cardiovascular, metabolic, and renal health

Cardiovascular Diabetology
Cardiovascular-Kidney-Metabolic (CKM) syndrome progresses through distinct stages, from early metabolic risk factors to advanced cardiovascular disease and kidney dysfunction. Across these stages, exercise remains a central yet underutilized intervention,
Zacharias Papadakis
doaj   +1 more source